BCL3 Expression Is a Potential Prognostic and Predictive Biomarker in Acute Myeloid Leukemia of FAB Subtype M2

Although the implication of BCL3 has been disclosed in human chronic lymphocytic leukemia as well as other solid tumors, the diagnostic and prognostic of BCL3 expression in acute myeloid leukemia (AML) remains largely unclear. In this study, we isolated total RNA from bone marrow mononuclear cells c...

Descripción completa

Detalles Bibliográficos
Autores principales: Niu, Yuna, Yang, Xue, Chen, Yifei, Zhang, Linbo, Jin, Xinyue, Tang, Youjing, Li, Li, Yu, Lu, Guo, Yilin, Wang, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449485/
https://www.ncbi.nlm.nih.gov/pubmed/30357752
http://dx.doi.org/10.1007/s12253-018-0476-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449485/
https://www.ncbi.nlm.nih.gov/pubmed/30357752
http://dx.doi.org/10.1007/s12253-018-0476-7

Ejemplares similares